Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases [6]

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1547-1548

  Leroux, Gaëlle ^a   Costedoat Chalumeau, Nathalie ^a,b   Hulot, Jean Sébastien ^a   Amoura, Zahir ^a   Francès, Camille ^a   Aymard, Guy ^a   Lechat, Philippe ^a   Piette, Jean Charles ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM ANTAGONIST; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; DEETHYLCHLOROQUINE; FLUCONAZOLE; HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RIFAMPICIN; SEROTONIN UPTAKE INHIBITOR;

BLOOD; CIGARETTE SMOKING; CONNECTIVE TISSUE DISEASE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIRHEUMATIC AGENTS; CHLOROQUINE; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; SMOKING;

EID: 35648946932     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.072587     Document Type: Letter

References (6)

1. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004;50:849-57.
2. Ghaussy NO, Sibbitt WL Jr, Qualls CR. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol 2001;28:2449-53.
3. Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol, 2000;42, 983-7.
4. Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 1998;25:1716-19.
5. Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54:3284-90.
6. Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Very low blood hydroxychloroquine concentrations as an objective marker of poor adherence to treatment in systemic lupus erythematosus. Ann Rheum Dis 2007;66:821-4.